Author: Alan Condon

Here are eight key developments from Rochester, Minn.-based Mayo Clinic in the past year, focused on its orthopedic, spine and neurosurgery services.

The anesthesia department at Northern Light Blue Hill (Maine) Hospital is providing a continuous peripheral nerve catheter as an alternative to postoperative pain management, reports The Ellsworth American.

Philadelphia-based Hahnemahn University Hospital decertified its position as a Level 1 and Level 2 trauma center, reports Philadelphia Business Journal.

Smith & Nephew completed the acquisition of Atracsys Sàrl, a Switzerland-based provider of optical tracking technology used in computer-assisted surgery.

Lumberton, N.C.-based Southeastern Neurological Center added Michael Wolak, MD, PhD, to its staff, reports The Robsonian.

The national opioid epidemic is one of the most pressing issues facing healthcare in the United States. Four spine and neurosurgeons provide their insight on how to tackle the opioid epidemic.

Here are eight spine and neurosurgeons making the news.

Saluda Medical acquired $75 million in equity financing from Boston Scientific and Redmile Group to fund the finishing stages of its Evoke evoked action compound potential-controlled, Closed-Loop Spinal Cord Stimulation System.

Fusion Robotics closed its financing round for an undisclosed figure with lead investment by Alex Lukianov of Lukpartners and Kevin Foley, MD.

Alexion Pharmaceuticals' Soliris received FDA approval for the treatment of neuromyelitis optica spectrum disorder in adult patients who test positive for the anti-aquaporin-4 antibody.